SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-059592
Filing Date
2020-05-11
Accepted
2020-05-11 16:38:54
Documents
97
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2014620-1_10q.htm 10-Q 1402010
2 EXHIBIT 31.1 tm2014620d1_ex31-1.htm EX-31.1 11552
3 EXHIBIT 31.2 tm2014620d1_ex31-2.htm EX-31.2 11237
4 EXHIBIT 32.1 tm2014620d1_ex32-1.htm EX-32.1 4399
5 EXHIBIT 32.2 tm2014620d1_ex32-2.htm EX-32.2 4429
  Complete submission text file 0001104659-20-059592.txt   10821859

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fbio-20200331.xml EX-101.INS 3208192
7 XBRL TAXONOMY EXTENSION SCHEMA fbio-20200331.xsd EX-101.SCH 95002
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fbio-20200331_cal.xml EX-101.CAL 76845
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fbio-20200331_def.xml EX-101.DEF 291885
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbio-20200331_lab.xml EX-101.LAB 591311
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbio-20200331_pre.xml EX-101.PRE 541823
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 20865497
SIC: 2834 Pharmaceutical Preparations